Gastroesophageal reflux disease: New treatments

Reviews in Gastroenterological Disorders

Volumn 2, Issue 2, 2002, Pages 66-74

  Katz, Philip O ^a  

^a GRADUATE HOSPITAL   (United States)

Author keywords

Adenocarcinoma; Antireflux surgery; Barrett's esophagus; Gastroesophageal reflux disease; Proton pump inhibitors

Indexed keywords

AMINOBUTYRIC ACID DERIVATIVE; CISAPRIDE; CYTOCHROME P450 2C19; CYTOCHROME P450 3A4; ESOMEPRAZOLE; LANSOPRAZOLE; METOCLOPRAMIDE; OMEPRAZOLE; PANTOPRAZOLE; PROKINETIC AGENT; PROTON PUMP INHIBITOR; RABEPRAZOLE; STOMACH SECRETION INHIBITOR; SUCRALFATE;

ANTIREFLUX OPERATION; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; DRUG WITHDRAWAL; ENDOSCOPIC THERAPY; ESOPHAGUS STRICTURE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HOSPITALIZATION; HUMAN; LOWER ESOPHAGUS SPHINCTER; METABOLIC CLEARANCE RATE; MORBIDITY; QUALITY OF LIFE; RADIOFREQUENCY; REFLUX ESOPHAGITIS; REVIEW; SIDE EFFECT; STOMACH FUNDOPLICATION; STOMACH SURGERY; SUTURING METHOD; SYMPTOM;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-ULCER AGENTS; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HUMANS; LENGTH OF STAY; OMEPRAZOLE; PROTON PUMPS; TREATMENT OUTCOME;

EID: 0036072579     PISSN: 1533001X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Appropriate acid suppression for the management of gastro-oesophageal reflux disease
2. Control of TLOSRs and reflux by the GABAB agonist baclofen in patients with gastro-oesophageal reflux disease
3. Healing and relapse rates in GERD treated with the newer PPIs lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: Evidence from randomized clinical trials
4. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis
5. Double-blind, placebo controlled comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease
6. A double blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: A multicentre trial
7. A PPI is a PPI. Lessons from prolonged pH monitoring
8. Management of heartburn in a large randomized community-based study: Comparison of four therapeutic strategies
9. Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily
10. Pharmacokinetic studies with esomeprazole, the (S) isomer of omeprazole
11. Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro-oesophageal reflux disease
12. Esomeprazole 40 mg provides more effective acid control than omeprazole 40 mg
13. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: A randomized controlled trial
14. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: A randomized controlled trial
15. Esomeprazole (40mg) compared with lansoprazole (30mg) in the treatment of erosive esophagitis
16. Corpus gastritis is protective against reflux oesophagitis
17. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: A randomized, double-blind, placebo-controlled study of safety
18. Esomeprazole is effective as maintenance therapy in GERD patients with healed erosive esophagitis (EE)
19. Predictors of outcome in 100 consecutive laparoscopic antireflux procedures
20. An evidence-based appraisal of reflux disease management: The Genval Workshop report
21. Gastro-oesophageal reflux related cough and its response to laparoscopic fundoplication
22. Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication
23. A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux
24. Outcomes of atypical symptoms attributed to gastroesophageal reflux treated by laparoscopic fundoplication
25. Continued (5-year) follow up of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease
26. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: Follow up of a randomized controlled trial
27. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans
28. Obesity adversely affects the outcome of antireflux operations
29. A prospective multicenter study on laparoscopic treatment of gastroesophageal reflux disease in Italy: Type of surgery, conversions, complications, and early results
30. Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery
31. Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: Randomized clinical trial
32. Functional outcome after laparoscopic or open Nissen fundoplication: A follow up study
33. Radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD
34. Transoral endoscopic suturing for gastroesophageal reflux disease: A multicenter trial
35. Endoscopic gastric plication for the treatment of GERD; two-year follow up results
36. Enteryx solution, a minimally invasive injectable treatment for GERD: Initial multicenter human trial results